Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Classical PCOS types A and B are most common and linked to higher health risks.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Type 2 diabetes in youth is increasing, with high treatment failure rates and more severe than Type 1; certain drugs can lower lipid levels effectively with varying side effects, and apples may benefit heart health like statins but with fewer side effects.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Physical activity, height, and smoking affect prostate cancer risk.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Hair loss is a common side effect of hormone treatments for cancer.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

PCOS has many symptoms, with high androgen levels being the most common.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Ginseng is possibly safe but its effectiveness is unclear due to poor quality studies and mixed results.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Bariatric surgery improves skin conditions and metabolism but may cause nutritional deficiencies and hair loss.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.